PRESS RELEASE, 2006-11-14

Johns Hopkins Bayview Proteomics Center chooses Ludesi

Lund, Sweden - November 14, 2006 -- Ludesi AB, a global provider of bioinformatics solutions to the life science industry, today announced that Johns Hopkins Bayview Proteomics Center, Baltimore, has selected Ludesi for its complete image analysis processing of two-dimensional gels.

The Johns Hopkins Bayview Proteomics Center has selected Ludesi for its gel image analysis obtained from two-dimensional (2D) gel electrophoresis, a key technology within the growing field of expression proteomics.

“Ludesi offers the industry’s by far most accurate option when it comes to 2D gel image analysis. Our technology is uncovering crucial information in 2D gel images that conventional 2D gel software doesn’t find because of analysis errors. The unparalleled accuracy of Ludesi’s image analysis is the main reason that leading scientists have chosen our solution,” comments Ola Forsstrom-Olsson, CEO at Ludesi.

Johns Hopkins Bayview Proteomics Center is directed by Dr. Jennifer Van Eyk. Dr. Van Eyk is an associate professor in the departments of medicine, biological chemistry and biomedical engineering at Johns Hopkins School of Medicine. Dr. Van Eyk is a Fellow of the American Heart Association, and a member of the editorial boards of the following journals; Circulation Research, Journal of Physiology, Proteomics, and Proteomics: Clinical Applications. Her research group focuses on the use and optimization of proteomic analysis of tissue and serum for the development of treatment and diagnostics for heart disease.

“Johns Hopkins Bayview Proteomics Center and Johns Hopkins School of Medicine is world-renowned for scientific excellence and front-end applied medical research. It is an honor to work with such successful and skilled scientists,” concludes Mr. Forsstrom-Olsson.

About Johns Hopkins Bayview Proteomics Center

Johns Hopkins Bayview Proteomics Center applies state-of-the-art methods and develops new approaches and techniques to investigate a biological process of broad interest to heart, lung and blood diseases. Further information can be found at www.proteomics.jhu.edu

For further information, please contact:

Ola Forsstrom-Olsson, CEO, Ludesi
Phone: +46-46-286-5510
Mobile: +46-708-122-548
E-mail: ola.forsstrom-olsson@ludesi.com